PL2193133T3 - Imidazolotiadiazole do stosowania jako inhibitory kinazy białkowej - Google Patents
Imidazolotiadiazole do stosowania jako inhibitory kinazy białkowejInfo
- Publication number
- PL2193133T3 PL2193133T3 PL08806437T PL08806437T PL2193133T3 PL 2193133 T3 PL2193133 T3 PL 2193133T3 PL 08806437 T PL08806437 T PL 08806437T PL 08806437 T PL08806437 T PL 08806437T PL 2193133 T3 PL2193133 T3 PL 2193133T3
- Authority
- PL
- Poland
- Prior art keywords
- imidazolothiadiazoles
- protein kinase
- kinase inhibitors
- inhibitors
- protein
- Prior art date
Links
- BOXRDDIXJOUZLV-UHFFFAOYSA-N 2h-imidazo[4,5-d]thiadiazole Chemical class N1SC2=NC=NC2=N1 BOXRDDIXJOUZLV-UHFFFAOYSA-N 0.000 title 1
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title 1
- 239000003909 protein kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07381066 | 2007-09-27 | ||
| PCT/GB2008/003287 WO2009040552A2 (en) | 2007-09-27 | 2008-09-29 | Substituted imidazo (2, 1-b) -1, 3, 4-thiazole compounds, their pharmaceutical compositions and uses thereof |
| EP08806437.3A EP2193133B1 (en) | 2007-09-27 | 2008-09-29 | Imidazolothiadiazoles for use as protein kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2193133T3 true PL2193133T3 (pl) | 2016-01-29 |
Family
ID=39092755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08806437T PL2193133T3 (pl) | 2007-09-27 | 2008-09-29 | Imidazolotiadiazole do stosowania jako inhibitory kinazy białkowej |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8563550B2 (OSRAM) |
| EP (1) | EP2193133B1 (OSRAM) |
| JP (1) | JP5410431B2 (OSRAM) |
| CN (1) | CN101878219B (OSRAM) |
| CY (1) | CY1116882T1 (OSRAM) |
| DK (1) | DK2193133T3 (OSRAM) |
| ES (1) | ES2548768T3 (OSRAM) |
| HR (1) | HRP20151128T1 (OSRAM) |
| HU (1) | HUE025976T2 (OSRAM) |
| PL (1) | PL2193133T3 (OSRAM) |
| PT (1) | PT2193133E (OSRAM) |
| SI (1) | SI2193133T1 (OSRAM) |
| WO (1) | WO2009040552A2 (OSRAM) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| HUE026303T2 (hu) | 2005-07-25 | 2016-06-28 | Emergent Product Dev Seattle | B-sejt csökkentés CD37-specifikus és CD20-specifikus kapcsoló molekulák alkalmazásával |
| CN105837690A (zh) | 2006-06-12 | 2016-08-10 | 新兴产品开发西雅图有限公司 | 具有效应功能的单链多价结合蛋白 |
| SI2193133T1 (sl) | 2007-09-27 | 2015-12-31 | Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii | Imidazolotiadiazoli za uporabo kot zaviralci protein-kinaze |
| AU2009234277B2 (en) | 2008-04-11 | 2014-12-04 | Aptevo Research And Development Llc | CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| EP2307425B1 (en) * | 2008-07-29 | 2014-03-26 | Merck Patent GmbH | Imidazothiadiazoles derivatives |
| PL2414369T3 (pl) * | 2009-04-02 | 2016-04-29 | Fundacion Centro Nac De Investigaciones Oncologicas Carlos Iii | Pochodne imidazo[2,1-b][1,3,4]tiadiazolu |
| FR2945289A1 (fr) * | 2009-05-11 | 2010-11-12 | Sanofi Aventis | Derives de 2-cycloamino-5-(pyridin-4-yl)imidazo°2,1-b! °1,3,4!thiadiazole, leur preparation et leur application en therapeutique |
| CA2775204A1 (en) | 2009-09-24 | 2011-03-31 | Centro Nacional De Investigaciones Oncologicas (Cnio) | Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors |
| PH12012501361A1 (en) | 2009-12-31 | 2012-10-22 | Centro Nac De Investigaciones Oncologicas Cnio | Tricyclic compounds for use as kinase inhibitors |
| JP2013519719A (ja) | 2010-02-18 | 2013-05-30 | セントロ ナシオナル デ インベスティガシオネス オンコロヒカス（セエネイオ） | トリアゾロ［４，５−ｂ］ピリジン誘導体 |
| WO2011121317A1 (en) | 2010-04-01 | 2011-10-06 | Centro Nacional De Investigaciones Oncologicas (Cnio) | Imidazo [2,1-b] [1,3,4] thiadiazoles as protein or lipid kinase inhibitors |
| EP3399026B1 (en) | 2010-06-14 | 2024-06-26 | The Scripps Research Institute | Reprogramming of cells to a new fate |
| WO2012020215A1 (en) | 2010-08-09 | 2012-02-16 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors |
| WO2012020217A1 (en) | 2010-08-09 | 2012-02-16 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors |
| WO2012020227A1 (en) | 2010-08-11 | 2012-02-16 | Centro Nacional De Investigaciones Oncologicas (Cnio) | Tricyclic compounds for use as kinase inhibitors |
| EP2655362A1 (en) | 2010-12-22 | 2013-10-30 | Abbvie Inc. | Hepatitis c inhibitors and uses thereof |
| WO2012098387A1 (en) | 2011-01-18 | 2012-07-26 | Centro Nacional De Investigaciones Oncológicas (Cnio) | 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors |
| CA2872979C (en) | 2011-05-19 | 2020-02-18 | Joaquin Pastor Fernandez | Macrocyclic compounds as protein kinase inhibitors |
| WO2013005057A1 (en) | 2011-07-07 | 2013-01-10 | Centro Nacional De Investigaciones Oncológicas (Cnio) | New compounds |
| WO2013005041A1 (en) | 2011-07-07 | 2013-01-10 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Tricyclic heterocyclic compounds as kinase inhibitors |
| WO2013004984A1 (en) | 2011-07-07 | 2013-01-10 | Centro Nacional De Investigaciones Oncologicas (Cnio) | Tricyclic compounds for use as kinase inhibitors |
| EP2671885A1 (en) * | 2012-06-05 | 2013-12-11 | Ares Trading S.A. | Imidazo-oxadiazole and Imidazo-thiadiazole derivatives |
| EP2682395A1 (en) | 2012-07-04 | 2014-01-08 | Laboratorios Del. Dr. Esteve, S.A. | Imidazo[2,1-b]thiazole derivatives, their preparation and use as medicaments |
| WO2014015167A2 (en) * | 2012-07-18 | 2014-01-23 | University Of Notre Dame Du Lac | 5,5-heteroaromatic anti-infective compounds |
| WO2017053469A2 (en) | 2015-09-21 | 2017-03-30 | Aptevo Research And Development Llc | Cd3 binding polypeptides |
| CN108697709A (zh) | 2015-12-10 | 2018-10-23 | Ptc医疗公司 | 用于治疗亨廷顿病的方法 |
| US20190119300A1 (en) * | 2016-04-18 | 2019-04-25 | Vanderbilt University | Substituted and fused 6-membered protease activated receptor 4 (par-4) antagonists |
| AU2018282154B2 (en) | 2017-06-05 | 2022-04-07 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| CN111182898B (zh) | 2017-06-28 | 2024-04-16 | Ptc医疗公司 | 用于治疗亨廷顿氏病的方法 |
| WO2019005993A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | METHODS OF TREATING HUNTINGTON'S DISEASE |
| BR112020019373A2 (pt) | 2018-03-27 | 2020-12-29 | Ptc Therapeutics, Inc. | Compostos para o tratamento da doença de hutington |
| IL279688B2 (en) | 2018-06-27 | 2025-01-01 | Ptc Therapeutics Inc | Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease |
| EP3814360B8 (en) | 2018-06-27 | 2024-11-06 | PTC Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| WO2020005877A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| TWI811428B (zh) * | 2018-08-21 | 2023-08-11 | 日商杏林製藥股份有限公司 | 雙環雜芳香環衍生物 |
| JP7634532B2 (ja) * | 2019-10-21 | 2025-02-21 | ノバルティス アーゲー | 寄生虫病の処置のための化合物及び組成物 |
| JP2024544036A (ja) * | 2021-11-29 | 2024-11-26 | オーシャン ユニバーシティ オブ チャイナ | イミダゾチアゾール誘導体およびその製造方法と使用 |
| CN114195736B (zh) * | 2021-12-30 | 2023-08-04 | 浙江闰土染料有限公司 | 2-氨基-5-溴-1,3,4-噻二唑的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1464259A (en) | 1975-10-03 | 1977-02-09 | Pfizer Ltd | Imidazo-thiazole and -thiadiazole sulphonamides and their use as therapeutic agents |
| US4444770A (en) | 1980-05-29 | 1984-04-24 | Bayer Aktiengesellschaft | New imidazoazole-alkenoic acid amide compounds, intermediate products for their production, their production, and their medicinal use |
| DE3208437A1 (de) | 1982-03-09 | 1983-09-15 | Bayer Ag, 5090 Leverkusen | Imidazothiadiazolalkencarbonsaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln |
| IT1269176B (it) | 1994-01-11 | 1997-03-21 | Isagro Srl | Eterobicicli ad attivita' fungicida |
| WO1997011075A1 (en) | 1995-09-22 | 1997-03-27 | Takeda Chemical Industries, Ltd. | Triazole compounds, their production and use |
| HK1052354A1 (zh) | 2000-08-09 | 2003-09-11 | Agouron Pharmaceuticals, Inc. | 吡唑-噻唑化合物，包括它们的药物组分，和他们在抑制细胞周期蛋白依赖性激酶用途的方法 |
| CA2364985A1 (en) * | 2001-12-14 | 2003-06-14 | John W. Gillard | Imidazo(2,1-b)thiadiazole sulfonamides |
| AU2003297161B8 (en) | 2002-12-18 | 2011-03-31 | Vertex Pharmaceuticals Incorporated | Triazolopyridazines as protein kinases inhibitors |
| PA8595001A1 (es) | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
| JP2006527209A (ja) * | 2003-06-13 | 2006-11-30 | アエジェラ・セラピューティクス・インコーポレーテッド | アシル化及び非−アシル化イミダゾ［２，１−ｂ］−１，３，４−チアジアゾール−２−スルホンアミド及びその使用 |
| EP1636241A1 (en) * | 2003-06-13 | 2006-03-22 | Aegera Therapeutics Inc. | Imidazo (2,1-b) -1,3,4-thiadiazole sulfoxides and sulfones |
| EP1912966A2 (en) * | 2005-06-01 | 2008-04-23 | Ucb, S.A. | 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| WO2007025090A2 (en) | 2005-08-25 | 2007-03-01 | Kalypsys, Inc. | Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase |
| US7750000B2 (en) | 2005-09-02 | 2010-07-06 | Bayer Schering Pharma Ag | Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments |
| JP5144532B2 (ja) | 2005-11-30 | 2013-02-13 | バーテックス ファーマシューティカルズ インコーポレイテッド | ｃ−Ｍｅｔ阻害剤及び用法 |
| BRPI0710133A2 (pt) | 2006-04-13 | 2012-10-30 | Aegera Therapeutics Inc | uso de compostos de imidazo[2,1-b]-1,3,4-tiadiazol-2-sulfonamida para tratar dor neuropática |
| WO2007136730A2 (en) | 2006-05-21 | 2007-11-29 | Steven Allen Carlson | Systems and methods for hydrogen storage and generation |
| CN101037445A (zh) | 2007-04-14 | 2007-09-19 | 西北师范大学 | 一种具有潜在生物活性的咪唑并[2，1－b]－1，3，4－噻二唑衍生物及其合成方法 |
| PE20090215A1 (es) | 2007-05-09 | 2009-03-30 | Novartis Ag | Compuestos derivados de imidazopiridazinas como inhibidores de cinasa |
| WO2008144767A1 (en) * | 2007-05-21 | 2008-11-27 | Sgx Pharmaceuticals, Inc. | Heterocyclic kinase modulators |
| SI2193133T1 (sl) | 2007-09-27 | 2015-12-31 | Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii | Imidazolotiadiazoli za uporabo kot zaviralci protein-kinaze |
| EP2307425B1 (en) | 2008-07-29 | 2014-03-26 | Merck Patent GmbH | Imidazothiadiazoles derivatives |
-
2008
- 2008-09-29 SI SI200831527T patent/SI2193133T1/sl unknown
- 2008-09-29 DK DK08806437.3T patent/DK2193133T3/en active
- 2008-09-29 PT PT88064373T patent/PT2193133E/pt unknown
- 2008-09-29 WO PCT/GB2008/003287 patent/WO2009040552A2/en not_active Ceased
- 2008-09-29 JP JP2010526362A patent/JP5410431B2/ja not_active Expired - Fee Related
- 2008-09-29 ES ES08806437.3T patent/ES2548768T3/es active Active
- 2008-09-29 US US12/679,514 patent/US8563550B2/en not_active Expired - Fee Related
- 2008-09-29 HU HUE08806437A patent/HUE025976T2/en unknown
- 2008-09-29 CN CN200880118104.5A patent/CN101878219B/zh not_active Expired - Fee Related
- 2008-09-29 HR HRP20151128TT patent/HRP20151128T1/hr unknown
- 2008-09-29 PL PL08806437T patent/PL2193133T3/pl unknown
- 2008-09-29 EP EP08806437.3A patent/EP2193133B1/en active Active
-
2015
- 2015-11-03 CY CY20151100982T patent/CY1116882T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1116882T1 (el) | 2017-04-05 |
| ES2548768T3 (es) | 2015-10-20 |
| DK2193133T3 (en) | 2015-10-05 |
| CN101878219B (zh) | 2014-04-02 |
| JP2010540508A (ja) | 2010-12-24 |
| HRP20151128T1 (hr) | 2015-11-20 |
| JP5410431B2 (ja) | 2014-02-05 |
| US20110190289A1 (en) | 2011-08-04 |
| US8563550B2 (en) | 2013-10-22 |
| WO2009040552A2 (en) | 2009-04-02 |
| WO2009040552A3 (en) | 2009-05-22 |
| CN101878219A (zh) | 2010-11-03 |
| HUE025976T2 (en) | 2016-05-30 |
| EP2193133B1 (en) | 2015-08-19 |
| EP2193133A2 (en) | 2010-06-09 |
| SI2193133T1 (sl) | 2015-12-31 |
| PT2193133E (pt) | 2015-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1900014I1 (hu) | Proteinkináz inhibitorok | |
| PL2193133T3 (pl) | Imidazolotiadiazole do stosowania jako inhibitory kinazy białkowej | |
| IL206416A0 (en) | Benzofuropyrimidinones as protein kinase inhibitors | |
| EP2200436A4 (en) | SUBSTITUTED PYRIMIDINYLAMINE AS PROTEIN KINASENHEMMER | |
| IL210073A0 (en) | Protein kinase inhibitors | |
| IL210069A0 (en) | Protein kinase inhibitors | |
| SI2201012T1 (sl) | Derivati pirolo(2,3-D)pirimidina kot inhibitorji proteina kinaze B | |
| PL2610256T3 (pl) | Pochodne pirymidyny jako inhibitory kinaz białkowych | |
| IL198487A0 (en) | 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors | |
| ZA201004942B (en) | Ptrrolopyrazine kinase inhibitors | |
| IL198398A0 (en) | 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors | |
| ZA201102423B (en) | Imidazopyridazinecarbonitriles useful as kinase inhibitors | |
| EP1993539A4 (en) | THIAZOLONE AS A PI3 KINASE INHIBITOR | |
| IL209729A0 (en) | Novel phenylpyrazinones as kinase inhibitors | |
| ZA201005166B (en) | 2-benzylpyridazinone derivatives as met kinase inhibitors | |
| EP2336123A4 (en) | HETEROCYCLIC COMPOUND AS INHIBITOR OF PROTEIN KINASE | |
| EP1993535A4 (en) | THIAZOLONE AS A PI3 KINASE INHIBITOR | |
| IL194491A0 (en) | Thiazolyldihydroindazole derivatives as protein kinase inhibitors | |
| EP1993537A4 (en) | THIAZOLONES AS INHIBITORS OF P13-KINASES | |
| EP1993536A4 (en) | THIAZOLONES AS INHIBITORS OF P13-KINASES | |
| EP1996191A4 (en) | THIAZOLONE AS A PI3 KINASE INHIBITOR | |
| ZA200810573B (en) | Substituted 3-cyanopyridines as protein kinase inhibitors | |
| IL197981A0 (en) | Kinase inhibitors | |
| EP1993538A4 (en) | THIAZOLONES AS INHIBITORS OF P13-KINASES | |
| GB0715470D0 (en) | IKK- serine-threonine protein kinase inhibitors |